Reuters —
The U.S. Food and Drug Administration said on Tuesday it would allow Philip Morris to market its Zyn nicotine pouches as less harmful than cigarettes.
The agency allowed the company to market 20 variants of Zyn products with the claim that “using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.”
Popular nicotine pouch products had been awaiting the agency’s clearance as scientists hesitated due to potential risks to new users, including children.
Tobacco companies have also been lobbying U.S. President Donald Trump and other key officials this year for changes they favor, including a faster, clearer FDA authorization process.
